Your browser doesn't support javascript.
loading
PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects.
Munari, Enrico; Mariotti, Francesca R; Quatrini, Linda; Bertoglio, Pietro; Tumino, Nicola; Vacca, Paola; Eccher, Albino; Ciompi, Francesco; Brunelli, Matteo; Martignoni, Guido; Bogina, Giuseppe; Moretta, Lorenzo.
Afiliación
  • Munari E; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.
  • Mariotti FR; Immunology Area, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
  • Quatrini L; Immunology Area, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
  • Bertoglio P; Division of Thoracic Surgery, IRCCS Maggiore Teaching Hospital and Sant'Orsola University Hospital, 40133 Bologna, Italy.
  • Tumino N; Immunology Area, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
  • Vacca P; Immunology Area, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
  • Eccher A; Pathology Unit, University and Hospital Trust of Verona, 37134 Verona, Italy.
  • Ciompi F; Computational Pathology Group, Department of Pathology, Radboud University Medical Center, 6543 SH Nijmegen, The Netherlands.
  • Brunelli M; Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
  • Martignoni G; Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
  • Bogina G; Pathology Unit, Pederzoli Hospital, 37019 Peschiera del Garda, Italy.
  • Moretta L; Pathology Unit, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy.
Int J Mol Sci ; 22(10)2021 May 12.
Article en En | MEDLINE | ID: mdl-34066087

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia